Falsified and unauthorised imitation products containing GLP-1 active substances When GLP-1 products first began to attract public interest, there were repeated cases of products being falsified by label swapping
Initiating basal insulin therapy in type 2 diabetes: practical steps to optimize glycemic control
these changes do not make it a growth-hormone secretagogue, instead they sharply reduce its binding to IGF-binding proteins (IGFBPs), which is what extends its circulating half-life and potency relative to native IGF-1
Reactive oxygen species (ROS), produced via GSH-mediated pathways, can serve as danger-associated molecular patterns, stimulating dendritic cells and promoting T-cell expansion [82]
Whilst GLP-1 receptor agonists are not diuretics and do not typically cause polyuria, several factors associated with treatmentincluding improved glycaemic control, weight loss, and gastrointestinal effectscan influence urinary patterns
Cholesterol helps seal potential leakage pathways within bilayer membranes, creating a more robust structure as surfactants densely pack during formulation (Zolghadri et al., 2023)